Singapore markets open in 8 hours 34 minutes

Surgical Science Sweden AB (publ) (0AAU.L)

LSE - LSE Delayed price. Currency in SEK
Add to watchlist
135.00+6.10 (+4.73%)
At close: 04:54PM BST
Currency in SEK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.00
52-week change 3-15.75%
S&P500 52-week change 320.87%
52-week high 3264.80
52-week low 3119.50
50-day moving average 3169.93
200-day moving average 3179.52

Share statistics

Avg vol (3-month) 320.69k
Avg vol (10-day) 355.71k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 837.43M
% held by insiders 126.67%
% held by institutions 156.25%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 24.70%
Operating margin (ttm)11.73%

Management effectiveness

Return on assets (ttm)2.13%
Return on equity (ttm)4.70%

Income statement

Revenue (ttm)842.02M
Revenue per share (ttm)16.51
Quarterly revenue growth (yoy)-17.80%
Gross profit (ttm)N/A
EBITDA 188.87M
Net income avi to common (ttm)207.94M
Diluted EPS (ttm)2.19
Quarterly earnings growth (yoy)-52.20%

Balance sheet

Total cash (mrq)659.18M
Total cash per share (mrq)12.92
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)4.22
Book value per share (mrq)89.92

Cash flow statement

Operating cash flow (ttm)206.3M
Levered free cash flow (ttm)59.28M